MA28980B1 - 1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiques - Google Patents
1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiquesInfo
- Publication number
- MA28980B1 MA28980B1 MA29689A MA29689A MA28980B1 MA 28980 B1 MA28980 B1 MA 28980B1 MA 29689 A MA29689 A MA 29689A MA 29689 A MA29689 A MA 29689A MA 28980 B1 MA28980 B1 MA 28980B1
- Authority
- MA
- Morocco
- Prior art keywords
- hetero
- inhibitors
- heterocyclylethanes
- arylethanes
- tetra
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59218104P | 2004-07-29 | 2004-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28980B1 true MA28980B1 (fr) | 2007-11-01 |
Family
ID=35613661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29689A MA28980B1 (fr) | 2004-07-29 | 2007-02-21 | 1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiques |
Country Status (15)
Country | Link |
---|---|
KR (1) | KR20070043985A (es) |
AR (1) | AR049847A1 (es) |
BR (1) | BRPI0513793A (es) |
CR (1) | CR8876A (es) |
EC (1) | ECSP077208A (es) |
IL (1) | IL180846A0 (es) |
MA (1) | MA28980B1 (es) |
MX (1) | MX2007001188A (es) |
NO (1) | NO20071107L (es) |
PE (1) | PE20060382A1 (es) |
RU (1) | RU2344134C2 (es) |
TW (1) | TW200607493A (es) |
UA (1) | UA88018C2 (es) |
WO (1) | WO2006028590A1 (es) |
ZA (1) | ZA200700477B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI1009313A2 (pt) * | 2009-03-18 | 2018-01-30 | Medicure Int Inc | preparação farmacêutica transdérmica e administração de tirofiban |
BR112014030629B1 (pt) | 2012-06-11 | 2021-12-21 | Bristol-Myers Squibb Company | Prófármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino) quinazolin -2-il] piridina-3-sulfonamida e composição farmacêutica que os compreende |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003059873A1 (en) * | 2002-01-04 | 2003-07-24 | Poseidon Pharmaceuticals A/S | Potassium channel modulators |
-
2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/es unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/es not_active Application Discontinuation
- 2005-07-22 TW TW094125011A patent/TW200607493A/zh unknown
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/ko not_active Application Discontinuation
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/ru not_active IP Right Cessation
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en active Application Filing
- 2005-07-25 UA UAA200702125A patent/UA88018C2/ru unknown
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/pt not_active IP Right Cessation
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/es unknown
-
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/xx unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/es not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/es unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/fr unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2007107408A (ru) | 2008-09-10 |
BRPI0513793A (pt) | 2008-05-13 |
UA88018C2 (ru) | 2009-09-10 |
AR049847A1 (es) | 2006-09-06 |
MX2007001188A (es) | 2007-03-21 |
KR20070043985A (ko) | 2007-04-26 |
PE20060382A1 (es) | 2006-05-15 |
WO2006028590A1 (en) | 2006-03-16 |
CR8876A (es) | 2007-08-28 |
ZA200700477B (en) | 2009-08-26 |
IL180846A0 (en) | 2007-06-03 |
TW200607493A (en) | 2006-03-01 |
RU2344134C2 (ru) | 2009-01-20 |
ECSP077208A (es) | 2007-02-28 |
NO20071107L (no) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
MA29817B1 (fr) | Derives de prolinamide utilises comme modulateurs du canal sodium | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
BRPI0408369A (pt) | derivados de indol úteis para o tratamento de doenças | |
MA30427B1 (fr) | Derives bicycliques utilises comme inhibiteurs de cetp | |
PT1543011E (pt) | Composto de tienopirrolilo e furanopirrolilo e sua utilizacao como ligandos do receptor h4 da histamina | |
EA200801372A1 (ru) | Способы получения замещенных пиримидинов | |
DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
EA201370001A1 (ru) | Противовирусные составы для местного применения | |
MY139690A (en) | Sulfonamide derivatives for the treatment of diseases. | |
MY143390A (en) | Sulfonamide derivatives for the treatment of diseases. | |
EA200700934A1 (ru) | Производные пиримидина и их применение в качестве модуляторов cb2 | |
EA200301232A1 (ru) | Новые соединения арилсульфонамида и их применение для лечения ожирения, диабета типа ii и нарушений центральной нервной системы | |
EP1673078A4 (en) | BENZYL ETHER AND BENZYLAMINO BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE | |
DE60118003D1 (de) | Harnstoffderivate und ihre verwendung | |
PT1206474E (pt) | Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2 | |
EA200601462A1 (ru) | Соединения для лечения заболеваний | |
UA83311C2 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
NO20060278L (no) | Piperazinderivater og fremgangsmater for anvendelse | |
MXPA05009535A (es) | Compuestos de acido n - alquil - hidroxamico - isoindolilo y sus usos farmaceuticos. | |
EP1689713A4 (en) | BENZYLETHER AND BETA-SECRETASE BENZYLAMINO INHIBITORS FOR TREATING ALZHEIMER'S DISEASE | |
EA200601217A1 (ru) | Новые конденсированные пирролокарбазолы | |
EA200601219A1 (ru) | Новые конденсированные пирролокарбазолы | |
BRPI0411085A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv |